ICM
DAVA icon

Invenomic Capital Management’s Endava DAVA Stock Holding History

Invenomic Capital Management’s Portfolio DAVA Stock Details DAVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$408K Sell
144,240
-566,105
-80% -$2.09M 0.02% 110
2026
Q1 		$3.14M Sell
710,345
-31,915
-4% -$176K 0.14% 119
2025
Q4 		$4.69M Buy
+742,260
New +$5.68M 0.22% 114

Other funds holding DAVA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
CU
CDAM (UK) London, United Kingdom $387M AUM 4.05% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return
KA
Kerrisdale Advisers Miami, Florida $399M AUM 42.87% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Invenomic Capital Management's DAVA Position: Q2 2026 in Review

Invenomic Capital Management reduced its Endava (DAVA) stake by 80% in Q2 2026, selling an estimated $2.09M and leaving 144,240 shares worth $408K. The position accounts for 0.02% of the portfolio, ranked #110.

Invenomic Capital Management first reported a position in DAVA in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.69M in Q4 2025. 72 funds tracked by Wall St. Rank hold DAVA as of Q2 2026.

  • Invenomic Capital Management held 144,240 shares of Endava worth $408K as of Q2 2026.
  • Invenomic Capital Management sold 566,105 Endava shares in Q2 2026, an estimated $2.09M.
  • Endava made up 0.02% of Invenomic Capital Management's portfolio in Q2 2026, its #110 holding.
  • Invenomic Capital Management first reported a position in Endava in Q4 2025 and has held it in 3 quarters since.
  • Invenomic Capital Management's Endava position peaked at $4.69M in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Endava as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.